Investing Profile

Maha Katabi

InvestorVC
General Partner at Sofinnova Investments
Photo of Maha Katabi, General Partner at Sofinnova Investments

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Sofinnova Investments General Partner
$100K - $5.0M
$1.5M
14
CompanyStageDateRound SizeTotal Raised
Star Therapeutics
Series DSep 2025$130M
Series CSep 2023$90M
$220M
Co-investors: Carl Gordon (OrbiMed), Jason P. Hafler (Sanofi Ventures)
ARTBIO
Series BJul 2025$130M
$250M
Co-investors: Alexander Pasteur (F-Prime Capital Partners), Jeffrey Tong (Third Rock Ventures)
Marea Therapeutics
Series BJun 2024$190M
$260M
Co-investors: Charles Homcy (Third Rock Ventures), Jeffrey Tong (Third Rock Ventures), Aaron Royston (venBio), Chris Garabedian (Perceptive Advisors)
Quanta Therapeutics
Series DMay 2023$51M
$110M
Co-investors: Arjun Goyal (Vida Ventures)
RayzeBio
Series DSep 2022$160M
$420M
Co-investors: Aaron Royston (venBio), bong koh (KohFounders)
Gyroscope Therapeutics
Series CMar 2021$150M
$210M
Co-investors: Robert Tansley (Cambridge Innovation Capital), Wouter Joustra (Forbion), Dmitrij Hristodorov (Forbion)
Vera Therapeutics
Series CJan 2021$80M
Series UnknownSep 2019$34M
$110M
Co-investors: Kurt von Emster (Abingworth)
Aerovate Therapeutics
Series AAug 2020$73M
$73M